Pfizer has moved to dismiss a lawsuit from a whistleblower who revealed problems at testing sites

A whistleblower launched a suit against Pfizer after revealing problems from their testing sites for the COVID-19 vaccine.

Pfizer CEO Albert Bourla

Brook Jackson, the whistleblower alleged that Pfizer violated clinical trial regulations and federal laws which include the False Claims Act. Pfizer has responded with a motion to dismiss.

From the Epoch Times:

In its motion to dismiss, Pfizer says the regulations don’t apply to its vaccine contract with the U.S. Department of Defense because the agreement was executed under the department’s Other Transaction Authority (OTA), which gives contract holders the ability to skirt many rules and laws that typically apply to contracts.

That means that Jackson’s claim that Pfizer must still comply with the Federal Acquisition Regulations “is simply wrong,” Pfizer said.

Trending: CNN Nosedives Despite Trying To Be “Unbiased” & Featuring J6 Hearings [VIDEO]

In response to the accusation that they did not follow federal procurement laws, Pfizer claimed that they “didn’t have to—this was just for a prototype.”

Pfizer’s contract offers all kinds of dreadful protections and ways of bypassing normal stipulations and regulations.

Save on MyPillow products. Use promo code FedUp at checkout and save 40% off the MyPillow Complete Mattress Sleep System.

Paying $.19 billion for 100 million doses, the government granted a contract under the “prototype” provision which falls under the OTA. This was manageable through Pfizer falling under a “nontraditional defense contractor.”

Federal law defines nontraditional defense contractors as “an entity that is not currently performing and has not performed” a contract or subcontract for the Department of Defense for at least one year preceding the solicitation of the OTA agreement. Pfizer has dozens of contracts with the military.

That means the government certified “an absurd fiction” to use an OTA to grant the contract, Kathryn Ardizzone, counsel with Knowledge Ecology International, told The Epoch Times in an email.

So while Pfizer’s contract does potentially shield them from the FAR regulations which they failed to follow, it is clear that they never should have legally been able to receive such a contract in the first place.

It is not, however, set in stone that they are free and clear of the FAR. Their actual contract is silent on regulations appearing under FAR, and therefore the judge in the case will have to examine details of the contract and the law extra carefully before granting the motion to dismiss.

Join The Conversation. Leave a Comment.


We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.